Phenylbutyrate enhances OATP1C1-mediated thyroxine uptake in astrocytes from Mct8 missense mutant mice

OBJECTIVE: Monocarboxylate transporter 8 (MCT8) is essential for cellular thyroid hormone (TH) transport, and pathogenic variants cause Allan-Herndon-Dudley syndrome (AHDS). We aimed to investigate how the MCT8P253L point mutation, corresponding to human MCT8P321L, affects cerebral TH metabolism in mice and to evaluate whether the chemical chaperone sodium phenylbutyrate (NaPB) can modulate TH uptake and transporter expression in primary astrocytes, thereby providing insight into potential therapeutic strategies for MCT8 deficiency. METHODS: Mct8P253L/y mice were analyzed for Dio2 mRNA expression and DIO2 enzyme activity as markers of local TH status. Primary astrocytes from mutant and wild-type mice were used to assess T3 and T4 uptake and TH transporter expression after NaPB treatment, combining 3'-mRNA sequencing and mass spectrometry. RESULTS: Mct8P253L/y mice exhibited markedly increased DIO2 activity, consistent with cerebral hypothyroidism, whereas Dio2 mRNA levels remained unchanged. In primary astrocytes, NaPB did not restore MCT8P253L protein expression or T3 uptake but selectively increased T4 uptake. Mass spectrometry revealed that this effect was mediated by NaPB-induced upregulation of the alternative T4 transporter OATP1C1. Accordingly, T4 uptake was not increased in Oatp1c1-deficient astrocytes. NaPB treatment also elevated Slc16a2 and Slco1c1 transcript levels, although the underlying mechanisms remain to be elucidated. CONCLUSION: NaPB enhances astrocytic T4 uptake in Mct8P253L/y mice via induction of OATP1C1 independently of MCT8 restoration. While OATP1C1 expression at the adult human blood-brain barrier is limited, NaPB may induce alternative TH transporters in glial or endothelial cells, suggesting potential therapeutic benefit for patients with MCT8 deficiency.

Authors

Institutions

Publication Details

Journal
European Thyroid Journal
Published
2026-11-18
DOI
https://doi.org/10.1530/etj-26-0352
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Phenylbutyrate enhances OATP1C1-mediated thyroxine uptake in astrocytes from Mct8 missense mutant mice

Ulrich Schweizer, Doreen Braun, Esther Dall, Joana Schlimbach et al.
European Thyroid Journal
Thyroid Disorders and Treatments
article

Phenylbutyrate enhances OATP1C1-mediated thyroxine uptake in astrocytes from Mct8 missense mutant mice

Ulrich Schweizer, Doreen Braun, Esther Dall, Joana Schlimbach, Meike Helms
article en

Abstract

OBJECTIVE: Monocarboxylate transporter 8 (MCT8) is essential for cellular thyroid hormone (TH) transport, and pathogenic variants cause Allan-Herndon-Dudley syndrome (AHDS). We aimed to investigate how the MCT8P253L point mutation, corresponding to human MCT8P321L, affects cerebral TH metabolism in mice and to evaluate whether the chemical chaperone sodium phenylbutyrate (NaPB) can modulate TH uptake and transporter expression in primary astrocytes, thereby providing insight into potential therapeutic strategies for MCT8 deficiency. METHODS: Mct8P253L/y mice were analyzed for Dio2 mRNA expression and DIO2 enzyme activity as markers of local TH status. Primary astrocytes from mutant and wild-type mice were used to assess T3 and T4 uptake and TH transporter expression after NaPB treatment, combining 3'-mRNA sequencing and mass spectrometry. RESULTS: Mct8P253L/y mice exhibited markedly increased DIO2 activity, consistent with cerebral hypothyroidism, whereas Dio2 mRNA levels remained unchanged. In primary astrocytes, NaPB did not restore MCT8P253L protein expression or T3 uptake but selectively increased T4 uptake. Mass spectrometry revealed that this effect was mediated by NaPB-induced upregulation of the alternative T4 transporter OATP1C1. Accordingly, T4 uptake was not increased in Oatp1c1-deficient astrocytes. NaPB treatment also elevated Slc16a2 and Slco1c1 transcript levels, although the underlying mechanisms remain to be elucidated. CONCLUSION: NaPB enhances astrocytic T4 uptake in Mct8P253L/y mice via induction of OATP1C1 independently of MCT8 restoration. While OATP1C1 expression at the adult human blood-brain barrier is limited, NaPB may induce alternative TH transporters in glial or endothelial cells, suggesting potential therapeutic benefit for patients with MCT8 deficiency.

European Thyroid Journal
University of Bonn (DE)
Good health and well-being
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon